Skip to content

Moduration of anticancer effect by 4-methylumbelliferone

Moduration of anticancer effect by 4-methylumbelliferone - Moduration of anticancer effect by 4-methylumbelliferone

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000013937
Enrollment
300
Registered
2014-06-01
Start date
2013-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastrointestinal and hepato-biliary-pancreatic cancer

Interventions

None listed

Sponsors

Hirosaki University, Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: gastrointestinal and hepato-biliary-pancreatic cancer

Exclusion criteria

Exclusion criteria: non

Design outcomes

Primary

MeasureTime frame
inhibition of the grouth rate of cultured cancer tissue

Countries

Japan

Contacts

Public ContactDaisuke Kudo

Hirosaki University, Graduate School of Medicine Department of the Gastroenterological Surgery

aikopapa@cc.hirosaki-u.ac.jp0172-39-5079

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026